Biomarkers Market Growth Driven by Personalized Medicine Demand and Chronic Diseases
-
Global biomarkers market projected to reach $125.6 billion by 2031 with a CAGR of 10.4% due to increasing demand for personalized medicine and rising prevalence of chronic diseases.
-
Consumables segment leads the market driven by reagents, assay kits, and other essentials for biomarker analysis. Diagnostic biomarkers also hold a major share.
-
North America leads globally due to robust R&D and advanced diagnostic technologies, while Asia Pacific emerging as fastest growing region.
-
Strategic partnerships between companies, academics, and biopharma driving innovation in biomarker discovery and analytical platforms.
-
Key players include Roche Diagnostics, Thermo Fisher Scientific, Abbott Laboratories, but emerging contenders gaining share through omics technologies and data analytics.